Illustration of a person sleeping peacefully in bed, surrounded by sleep-related icons and graphs.
Digital Health News

Introducing Emma Up: A Revolutionary Sleep Solution Powered By Action-Oriented AI Coaching

Emma Up, the AI sleep coaching app created by Emma – The Sleep Company (the world’s largest D2C sleep brand), is excited to announce the launch of its new sound-based sleep tracking feature. This innovative addition utilizes AI technology to offer users comprehensive insights into their sleep patterns and lifestyle habits without the need for any additional […]

"FemaSeed: Revolutionizing Reproductive Healthcare"
Digital Health News

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting the significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today highlighted that its FemaSeed intratubal insemination product, a revolutionary approach to enhancing fertilization, is expected to […]

"Bladder Cancer Treatment Clinical Trial"
Digital Health News

CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer

CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced the first patient has been dosed in the PIVOT-006 Phase 3 clinical trial of cretostimogene for the treatment of patients with intermediate-risk NMIBC following transurethral resection of […]

"Ovarian Cancer Treatment Clinical Trial"
Digital Health News

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

 IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces that Memorial Sloan Kettering Cancer Center has joined MD Anderson Cancer Center in enrolling patients in a Phase 1/2 clinical trial evaluating IMUNON’s IMNN-001 in combination with bevacizumab in patients with advanced ovarian cancer. IMNN-001 is a DNA-based interleukin-12 (IL-12) […]

"PENTAX Medical i20c Video Endoscope Series"
Digital Health News

New Models of PENTAX Medical i20c Video Endoscope Series Obtain CE Marks

PENTAX Medical, a division of HOYA Group, have obtained CE marks for new models of PENTAX Medical i20c Video Endoscope Series – PENTAX Medical Video Colonoscope EC34-i20c, PENTAX Medical Video Upper GI Scope EG27-i20c and R/L Knob Adaptor OE-B17. In combination with PENTAX Medical INSPIRA™ Video Processor EPK-i8020c, the PENTAX Medical i20c Video Endoscope Series […]

"Alexandria Real Estate Equities Mental Health Initiatives"
Digital Health News

Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, continues to make a distinctive, steadfast and positive impact on the widespread and complex mental health crisis through one of the company’s bedrock social responsibility pillars that prioritizes […]

International Medical Graduates Exploring Opportunities in UK Medicine
Digital Health News

M3 launches ‘Pathway’ to Support International Medical Graduates Relocating to the UK’

M3 (EU) has announced the international launch of ‘ Pathway’, the latest addition to, the UK’s leading online community of more than 250,000 GMC-registered doctors. M3 (EU) recently unveiled the new, exclusive online platform, which is designed to provide comprehensive support for overseas doctors seeking to practice in the UK. In 2022, over 10,000 […]

"Decentralized Clinical Trials (DCTs) - Improved Patient Access"
Digital Health News

PCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical Trials

Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina. EmVenio is the largest provider of community-based clinical trial sites served with mobile research units. The acquisition, which is effective immediately, strengthens PCM Trials’ and EmVenio’s abilities to recruit and retain […]

Healthcare professionals discussing CGM technology at a conference.
Digital Health News

SIBIONICS Announces Participation in the 17th International Conference on Advanced Technologies and Treatments for Diabetes

SIBIONICS, the world’s third-largest continuous glucose monitoring (CGM) brand, announced that it will participate in the International Diabetes Technology Exhibition at the 17th Symposium on Diabetes at the 17th Symposium on Diabetese International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Florence, Italy, March 6-9, 2024. It will be showcasing its latest CGM solutions […]